10x Genomics (TXG) News Today $13.08 -0.37 (-2.75%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$13.80 +0.72 (+5.50%) As of 07:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TXG Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period 10x Genomics (NASDAQ:TXG) Short Interest Up 1,022.8% in JulyAugust 3 at 6:45 AM | marketbeat.com10x Genomics (NASDAQ:TXG) Shares Acquired by Allianz Asset Management GmbHAugust 3 at 4:41 AM | marketbeat.comShort Interest in 10x Genomics (NASDAQ:TXG) Expands By 1,022.8%August 3 at 3:51 AM | americanbankingnews.com10x Genomics (TXG) Projected to Post Quarterly Earnings on ThursdayAugust 1 at 6:18 AM | marketbeat.comWeiss Ratings Reiterates "Sell (E+)" Rating for 10x Genomics (NASDAQ:TXG)July 31, 2025 | americanbankingnews.com10x Genomics' (TXG) Sell (E+) Rating Reaffirmed at Weiss RatingsJuly 30, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading Up 4.7% - Here's What HappenedJuly 29, 2025 | marketbeat.com10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?July 29, 2025 | msn.com10x Genomics (NASDAQ:TXG) Shares Acquired by ARK Investment Management LLCJuly 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Sells 350,828 Shares of 10x Genomics (NASDAQ:TXG)July 27, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Stock Holdings Lessened by New York State Common Retirement FundJuly 27, 2025 | marketbeat.com10x Genomics Stock Earns RS Rating UpgradeJuly 25, 2025 | msn.comCwm LLC Buys 25,868 Shares of 10x Genomics (NASDAQ:TXG)July 25, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading 8.5% Higher - What's Next?July 22, 2025 | marketbeat.comQ3 EPS Estimates for 10x Genomics Raised by Leerink PartnrsJuly 21, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from AnalystsJuly 19, 2025 | marketbeat.com10x Genomics Inc (TXG) and A*STAR GIS Collaborate on TISHUMAP Study | TXG stock newsJuly 17, 2025 | gurufocus.com10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target DiscoveryJuly 17, 2025 | prnewswire.comWeiss Ratings Reiterates Sell (E+) Rating for 10x Genomics (NASDAQ:TXG)July 14, 2025 | marketbeat.com10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025July 10, 2025 | prnewswire.com10x Genomics (NASDAQ:TXG) Trading Down 6.1% - What's Next?July 7, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Shares Purchased by Summit Trail Advisors LLCJuly 3, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 350,118 Shares of 10x Genomics (NASDAQ:TXG)July 2, 2025 | marketbeat.comDiversified Trust Co Boosts Holdings in 10x Genomics (NASDAQ:TXG)July 1, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Rating Lowered to Hold at Wall Street ZenJune 28, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Given Sell (E+) Rating at Weiss RatingsJune 28, 2025 | marketbeat.comTXG - 10x Genomics Inc Ordinary Shares - Class A Chart - MorningstarJune 27, 2025 | morningstar.comMBank of America Forecasts Strong Price Appreciation for 10x Genomics (NASDAQ:TXG) StockJune 26, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading Up 7.3% Following Analyst UpgradeJune 25, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Given New $13.00 Price Target at BarclaysJune 24, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by AnalystsJune 24, 2025 | marketbeat.com10x Genomics: Stuck In NeutralJune 23, 2025 | seekingalpha.com10x Genomics Settles Patent Dispute With BrukerJune 23, 2025 | insidermonkey.comGAMMA Investing LLC Has $273,000 Holdings in 10x Genomics (NASDAQ:TXG)June 22, 2025 | marketbeat.comDelta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To KnowJune 17, 2025 | msn.com10x Genomics, Inc. (NASDAQ:TXG) Stock Position Decreased by Assenagon Asset Management S.A.June 14, 2025 | marketbeat.comWeiss Ratings Reaffirms "Sell (E+)" Rating for 10x Genomics (NASDAQ:TXG)June 12, 2025 | marketbeat.comBrown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental ConcernsJune 10, 2025 | msn.comTXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost ReductionsJune 10, 2025 | msn.com10x Genomics (NASDAQ:TXG) Stock Price Up 8% - Time to Buy?June 9, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading Down 4.6% - What's Next?June 3, 2025 | marketbeat.comJefferies Financial Group Inc. Lowers Holdings in 10x Genomics, Inc. (NASDAQ:TXG)June 1, 2025 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Given Average Recommendation of "Hold" by AnalystsMay 31, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading Up 4.2% - Still a Buy?May 30, 2025 | marketbeat.comInsider Selling: 10x Genomics, Inc. (NASDAQ:TXG) CFO Sells 4,044 Shares of StockMay 29, 2025 | marketbeat.comInsider Selling: 10x Genomics, Inc. (NASDAQ:TXG) Insider Sells 7,485 Shares of StockMay 29, 2025 | marketbeat.comInsider Selling: 10x Genomics, Inc. (NASDAQ:TXG) CEO Sells 9,343 Shares of StockMay 29, 2025 | marketbeat.comAdam Taich Sells 4,044 Shares of 10x Genomics, Inc. (NASDAQ:TXG) StockMay 28, 2025 | insidertrades.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 193,588 Shares of 10x Genomics, Inc. (NASDAQ:TXG)May 28, 2025 | marketbeat.com10x Genomics' (TXG) "Sell (E+)" Rating Reiterated at Weiss RatingsMay 28, 2025 | marketbeat.com Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address TXG Media Mentions By Week TXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼0.750.46▲Average Medical News Sentiment TXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼107▲TXG Articles Average Week Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Adaptive Biotechnologies News Pacific Biosciences of California News Twist Bioscience News Veracyte News Bio-Rad Laboratories News Vontier News Ralliant News Mirion Technologies News Sensata Technologies News Camtek News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXG) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXG Stock Alerts